Trial Profile
Randomized Phase II Study Evaluating Three Chemotherapies: [Irinotecan + Oxaliplatin (Irinox)], [Irinotecan + LV5FU2] and [Oxaliplatin + LV5FU2] as First Intention Treatment in Subjects With Metastatic Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Feb 2021
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Oxaliplatin (Primary) ; Fluorouracil; Folinic acid
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 03 Oct 2005 New trial record.